NEW YORK, Oct. 1, 2018 /PRNewswire/ -- Ember Therapeutics, Inc. (OTCPK: EMBT, the "Company"), a diversified New York-based pharmaceutical company developing targeted therapies for osteoarthritis, ...
We are actively working to enhance your experience by translating more content. However, please be aware that the page you are about to visit has not yet been translated. We appreciate your ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results